Pulmozyme
Pulmozyme is a medicine authorised by Swissmedic under authorisation number 52623. The authorisation holder is Roche Pharma (Schweiz) AG. The medicinal product code is Biotechnological medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 28 April 1994 and the authorisation is valid without a time limit. ATC code R05CB13 places the medicine in the group Cough and cold preparations.
| Authorisation number | 52623 |
|---|---|
| Name | Pulmozyme |
| Full name | Pulmozyme, Inhalationslösung |
| Authorisation holder | Roche Pharma (Schweiz) AG |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | B · Prescription only |
| ATC code | R05CB13 |
| First authorisation | 28 April 1994 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Pulmozyme, Inhalationslösung | B | 28 April 1994 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 14 | 5 x 6 | Ampulle(n) | R05CB13 | 03.02.0. | B |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Pulmozyme authorised in Switzerland?
Yes. Pulmozyme is authorised by Swissmedic under authorisation number 52623, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Pulmozyme have?
Pulmozyme is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Pulmozyme?
The authorisation holder is Roche Pharma (Schweiz) AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.